Department of Medicinal Chemistry, Elan Pharmaceuticals, 800 Gateway Boulevard, South San Francisco, CA 94080, United States.
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5791-4. doi: 10.1016/j.bmcl.2011.08.008. Epub 2011 Aug 9.
The structure-activity relationship (SAR) of a novel, potent and metabolically stable series of sulfonamide-pyrazoles that attenuate β-amyloid peptide synthesis via γ-secretase inhibition is detailed herein. Sulfonamide-pyrazoles that are efficacious in reducing the cortical Aβx-40 levels in FVB mice via a single PO dose, as well as sulfonamide-pyrazoles that exhibit selectivity for inhibition of APP versus Notch processing by γ-secretase, are highlighted.
本文详细介绍了一系列新型、有效且代谢稳定的磺胺吡唑类化合物的结构-活性关系(SAR),这些化合物通过γ-分泌酶抑制来减弱β-淀粉样肽的合成。通过单次口服给药,磺胺吡唑类化合物能够有效降低 FVB 小鼠皮质 Aβx-40 水平,并且磺胺吡唑类化合物对 γ-分泌酶抑制 APP 与 Notch 加工具有选择性,这些化合物得到了重点强调。